Past webinars

This webinar will discuss how and why administering both WAIS-5 and WMS-5 as part of a comprehensive evaluation (and integrating their results) can help you draw more and better conclusions from your evaluations. After reviewing the flexibility of WMS-5 administration and how to determine the most appropriate option for a given evaluation, we will look at the functional areas covered by pairing the WMS-5 with the WAIS-5 and how integrating and comparing scores from the two measures can enhance interpretation of your clients’ overall functioning.

Many individuals diagnosed with ADHD display motor challenges that may not receive proper assessment and intervention as more emphasis is placed on the cognitive and behavioral issues associated with this diagnosis. This webinar will discuss the prevalence and nature of motor challenges, and explore the potential for the co-occurrence of Developmental Coordination Disorder, in this population. Dr Tamplain will explain how assessment tools such as the Movement ABC-3 and BOT-3 can be useful in detecting motor concerns when working with individuals with ADHD.

Discover the new WAIS-5 scales and index applications in healthcare with our webinar. Explore clinical use for cognitive concerns and earn CE & CPD Credits.

Discover how WAIS-5 enhances clinical accuracy & saves time in private practice in our webinar. For psychologists in private-settings, earn 1.0 CE credit.

Therapeutic Assessment (TA) is a semi-structured form of collaborative psychological assessment that has been shown in research to positively impact clients. This webinar, presented by Stephen E. Finn, PhD, will cover the framework for using the MMPI-3 in Therapeutic Assessment and specific strategies for discussing MMPI-3 findings with clients in a therapeutic way.

The BOT-3 and Movement ABC-3 are both newly revised tools for assessing gross and fine motor coordination in children and young adults. Join this webinar to find out what's new with the revised versions, discover the unique characteristics of each test, and learn about the applications of both tools in clinical practice.

This 30-minute webinar will highlight the accuracy of the WAIS®-5 in identifying clinical subgroup differences that set examinees within these groups apart from the general population.

Join this one-hour webinar for a description and demonstration of the new BOT-3 features and additional items. Increase your understanding of what to expect and how the BOT-3 updates can enhance your practice. 

In this webinar, descriptions of the new WAIS®-5 subtests’ content, materials, administration, and scoring will be reviewed. Distinctions will be drawn between digital and paper administration and general tips will be provided to ensure you have confidence in smooth and efficient administration.

Get an overview of the new WAIS-5, with a focus on features that make it the most comprehensive, reliable, and easy-to-use cognitive ability measure available. Participants will also be familiarized with the benefits related to the normative sample, test structure, administration time, reliability and validity, special group studies, new subtests, and new Primary and Ancillary Index Scores.